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 Today I am a Doctor of Nursing Practice (Yay!).  I would not be able to say or 
have accomplished this achievement without those who have supported me throughout 
my tenure at University of San Diego.  I am grateful for the individual ways each one of 
you have stood by me and encouraged me. 
 Dr. Fuller, your passion as an educator is evident in all the work you do for us as 
your students.  Thank you for being so dedicated to my project.  I am so appreciative of 
your time and effort you have put into my education both within the classroom and as 
my Faculty Advisor.  I have greatly enjoyed working with you.   
 JoAnn and to all at Jacobson Pediatrics. Thank you for making my project 
possible.  You all were so welcoming from my first day of clinical and I am happy to 
have had my experience at a clinic with great cohesiveness among staff.  JoAnn, I have 
never grown so much professionally as I have working with you.  Your mentorship has 
truly been the best.  You find the positive in every situation and have been there to 
always motivate me when I needed it, because of you I will always remind myself to 
live life at 100%.  
 Mom and Dad, I am forever thankful to have grown up with two successful, 
hard-working parents.  The many positive experiences I have had would not have 
happened without you two always there to give advice when I am at a crossroad.  You 
have provided me with the ability to be able to choose where I want to be and have 
shaped me into the person I am today.  I aspire to be able to do the same as you have 
done for me.  Also to my Brother, your work ethic inspires me.  I hope on my new path 
as a DNP that I can go above and beyond for others the way I see you do each day.  I 
love you all unconditionally.  
 Most of all, to my Vincent.  I may say that I met you right before the most hectic 
years of my life; but when I think back to us meeting I know you came into my life at 
the perfect time.  Through all of the long stretches of work, class, and clinical, you never 
once complained.  Thank you for being my instant hype-man and always making sure 
there is a meal at home waiting for me. I am proud to be yours and I am so excited for 








Opening Statement: Purpose in Pursuing the DNP 
Since finishing my nursing degree I have had many wonderful opportunities and 
experiences functioning as a bedside nurse.  Working in the Neonatal Intensive Care 
Unit (NICU) has created a foundation in my nursing career for which I will forever be 
thankful.  I have known that I always wanted to advance my knowledge and clinical 
skills to the terminal practice degree in nursing; the Doctor of Nursing Practice (DNP).  
The decision to move from Chicago to San Diego created a complete transition for 
myself professionally.  The time I spent before beginning my program at University of 
San Diego allowed me to flourish and expand my understanding of the neonatal and 
pediatric populations as well as comprehend how different health care systems operate.  
Here now I begin to further delve into my program towards becoming a DNP and for 
that I am beyond excited to see what my future will bring.  
 My passion for the high-risk infant population has created a desire to help this 
patient population post-hospital stay through health prevention and promotion.  My 
current NICU background has influenced my interest into working with these infants as 
well as other specialty pediatric clinics upon finishing my degree.  I plan to continue to 
be an advocate and educator for patients and families, now at a higher level of care as a 
DNP.  My professional goal is to provide the best quality of life possible for children 
who may have had setbacks in their health and to help them reach their highest 
abilities.  In addition to a foundation of pediatric primary care knowledge, I am open to 
 4 
gain a variety of specialty care experiences in hopes to discover a new ambition in 
nursing that has not previously presented itself.  I am eager to grow into a new role as a 
DNP and to learn more about myself along the way. 
 The underpinnings of the Family/Pediatric DNP degree will provide an 
education across the lifespan that will be beneficial to the rest of my professional 
practice. It is a rewarding feeling to be a part of a new shift in nursing.  Achieving a 
doctoral degree will allow me to show both the value of the DNP as well as the great 
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Peanut allergies are the leading cause of death from food anaphylaxis.  In 2017, 
the National Association of Allergy and Infectious Disease (NIAID) issued a guideline 
for use by primary care providers to identify infants who would benefit from early 
peanut consumption.   Many providers have not yet implemented these guidelines in 
clinical practice.  The purpose of this project was to implement a practice change to 
improve assessment of risk factors for peanut allergies utilizing the NIAID guideline in 
infants at their six-month well-child examination at a pediatric primary care practice.  
Risk factors assessed included: a history of eczema and/or egg allergy categorized by 
eczema and egg allergy severity.  Family history, seen as a moderate risk factor for food 
allergy, was also assessed.  The risk assessment was implemented by creating a 
provider alert on six-month wellness forms and a field for documentation into the 
electronic health record.  Providers were given education materials for families of 
infants who would benefit from safe, early peanut consumption.  This project is 
important for clinical practice; infants begin consuming solid foods at or around six-
months of age and this is a critical time to address risk for future allergies and educate 
families on benefits of early consumption of allergenic foods, such as peanuts.  Primary 
Care providers in primary care play a pivotal role in addressing new practice change.  
This project provides a framework for provider identifications of at-risk infants to move 















 The Centers for Disease Control (2017) estimates that 4-6% of children suffer 
from food allergies.  In those children, 30.4% are allergic to more than one type of food 
(American Academy of Allergy, Asthma, and Immunology, n.d.).  The prevalence of 
food allergies has increased over the last two decades and is a growing public and 
global health concern, especially in westernized countries (Tang & Mullins, 2017).  It has 
been reported that peanut allergies in children in the United States (U.S.) increased from 
0.4% in 1999 to 2% in 2010 (Togias et al., 2017).  Food allergies are a lifelong issue 
carrying an extreme burden of disease for affected children whose families must be 
constantly aware to avoiding exposure and trigger risks. 
Allergies develop when the immune system overreacts to a foreign substance in 
the body.  Symptoms range from a mild rash and itching to a severe and possibly fatal 
episode of anaphylaxis.  Anaphylaxis occurs when there is a large drop in blood 
pressure, swelling of the airways making it difficult to breathe, and decreased blood 
supply to vital organs, making this a life-threatening emergency (National Institute of 
Allergy and Infectious Disease, 2016; Sicherer et al., 2017).  Peanut allergies in the U.S. 
are the greatest cause of death from food anaphylaxis and are on the rise. The upward 
trend in peanut allergies is thought to be due to the fact that allergies are epigenetic, 
meaning that they are affected by an interaction between heritable genetics and the 
environment.  In epigenetic conditions, certain aspects of one’s environment (i.e. diet, 
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lifestyle, climate) can trigger expression of a gene whereas other environments may not 
(Committee on Food Allergies, 2017).  A consensus statement notes indirect evidence 
that genetics plays a role in food allergy development and family history is a moderate 
risk factor (Sicherer et al., 2017). 
 Additional risk factors are associated with peanut allergies.  Atopic dermatitis 
(also known as “eczema”) is a skin condition that affects the skin barrier and causes 
inflammation and breakdown.  This inflammation of the skin makes an individual more 
sensitive when exposed to allergens and proteins in the environment, such as 
peanuts.  Individuals with co-existing egg allergies have an increased risk for peanut 
allergies (Sicherer et al., 2017). The increased prevalence of peanut allergies, occurring 
early in childhood, and seldom outgrown, has lead researchers to recommend early 
prevention due to increased risk considerations (Du Toit et al., 2015). 
The groundbreaking randomized control trial, known as the Learning Early 
About Peanut Allergy (LEAP) Trial, showed significant reduction in peanut allergy 
with early consumption of peanuts.  This large trial included 640 infants 4-11 months 
old diagnosed with severe eczema, egg allergy, or both.   Prior to randomization of each 
child, skin-prick tests were performed and those who were positive for peanut allergies 
were separated from those who were negative into two groups for analysis.  Each infant 
in the two groups (positive vs. negative skin-prick tests) was then randomly assigned to 
a peanut consumption or peanut avoidance group until 60 months old.  The 
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consumption group was defined at consuming 2 grams of peanut protein at one specific 
time during the first and second year of life, in addition to consuming 3 grams of 
peanut protein (12g or roughly 3 teaspoons of peanut butter) each week for 50% of the 
weeks during data collection (Du Toit et al., 2015).   
At the end of the trial, infants in the negative versus the positive skin-prick tests 
prior to randomization were evaluated to determine presence of peanut allergy.  In the 
group of infants with a negative skin-prick test at initiation, 13.7% in the peanut 
avoidance group had peanut allergies while only 1.9% of the peanut consumption 
group had peanut allergies; a relative risk reduction of 86.1%.  The infants with positive 
skin-prick tests in the peanut avoidance group, 35.5% had peanut allergies, whereas 
10.6% of infants in the peanut consumption group had peanut allergies at the end of 
data analysis; a relative risk reduction of 70%.  Authors stated these outcomes show that 
early consumption of peanuts can prevent allergies at both the primary, prior to the 
disease occurring, and secondary, targeting those at risk for disease, levels (Du Toit et 
al., 2015). 
 The LEAP trial was extremely successful in showing that early 
intervention in consumption of peanuts can significantly reduce allergy prevalence at 
five years of life.  Researchers performed a continuation of this study, the LEAP-On 
trial, to determine if tolerance to peanuts persisted after 12 months of avoiding 
consumption.  This study consisted of 550 participants from the LEAP trial who were 
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separated in to peanut avoidance and peanut consumption groups for 12 months after 
the LEAP trial.   At the end of this period, participants who consumed peanuts for the 
first 60 months of life then avoided for the 12 months had a 74% lower prevalence of 
peanut allergies than those participants who continued to avoid peanuts for the 72 
months that both trials collected data (Du Toit et al., 2016).  
Both the LEAP trial and LEAP-On study show that early peanut introduction 
into the infant diet can have lasting impact and reduction in allergy development.  The 
timing of food introduction is critical for allergy prevention.  A systematic review by 
Ierodiakonou et al. (2016) examined articles pertaining to various types of allergenic 
food and risk for sensitization.  Analysis specific to peanut introduction at 4-11 months 
of age found a reduced frequency of 18 cases of peanut allergies per 1000 individuals 
(with an incidence of 2.5%). 
The research outcomes described above have created a paradigm shift in 
practice.  This transition has moved from delaying peanut introduction in infants to 
promoting early consumption of peanuts; especially in those at-risk infants.  In 2017, the 
NIAID created a new guideline for providers to follow when infants are starting solid 
foods. The three-part guidelines are based on patient allergy risk.  Infants with severe 
eczema and/or egg allergy are the highest risk for developing peanut allergies and these 
infants should be seen by a specialist for allergy testing prior to consumption.  Infants 
with mild to moderate eczema and/or egg allergy should start consistent consumption 
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of peanuts at or around six months of age.  Finally, infants with no history of eczema 
and/or egg allergy are considered low risk and may start consuming peanuts with 
family preferences (Togias et al., 2017) (Table 1). 
Providers play a key role in both assessing risk as well as counseling families on 
early introduction of peanut containing foods.  Experts found that without the provider 
knowledge and implementation of updated guidelines, introduction of allergenic foods, 
such as peanuts is delayed due to false beliefs that these foods should not be consumed 
in infants with eczema (Fleischer et al., 2016).  A national consensus statement 
recommended that improved education and training of key stakeholders, such as 
primary care providers, is needed in order for allergy prevention to be employed.  
Education topics should include: risk factors and determinants of allergies, prevention 
strategies, and improving diagnosis (Sicherer et al., 2017).  
One small survey found that pediatric providers and allergists are more likely to 
follow by the new NIAID guideline recommendations on early peanut consumption 
compared to family practice providers (Abrams, Singer, Soller, & Chan, 2018). There 
continues to be a lack of global knowledge and education of these recommendations, 
along with routine implementation into practice.  
This gap in practice was the foundation of this project, the purpose of which was 
to implement a practice change to adequately assess risk factors for food allergies in 
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infants being seen for their six-month well-child examination at a small, three provider 
pediatric primary care office in Southern California. 
Evidence-Based Practice Model 
 
The Stevens Star Model of Knowledge Transformation was the framework for 
this project.  Components of the Stevens Star Model consider that research and 
knowledge occur in stages over time to build impact.  This model can be utilized for 
evidence-based practice when there are many different types of knowledge such as: 
randomized control trials, systematic reviews, guidelines, and consensus statements 
(Melnyk & Fineout-Overholt, 2015).  Understanding that evidence at all levels can have 
an effect on implementing new practice is the foundation of both the Stevens Star 
Model and this project.  The Steven’s Star Model provided simple, easy to follow 
guidance throughout the process of implementing peanut allergy risk assessment to 




 This project took place over an eight-month period at a small, urban practice 
with one lead physician, two nurse practitioners, three Medical Assistants (MA), and an 
office manager.  The clinic accepts all insurance types, with a predominance of patients 
having public insurance.  It is important to note that at this clinic there are no 
computers in the patient rooms; providers use electronic charting after the visit.  At 
each well-exam, the medical assistant (MA) presents the provider with a form 
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consisting of age-specific milestones and health surveillance prompts for the provider to 
utilize during the exam. 
 Infants included in the project were those presenting for a six-month wellness 
examination.  Six-month age was chosen because the American Academy of Pediatrics 
(AAP) recommends starting solid foods at or around six-months (American Academy 
of Pediatrics, 2019).  Infants were assessed for peanut allergy risk at the six-month 
wellness-examination utilizing the NIAID 2017 guideline (Togias et al., 2017).  Risk 
factors included: a history of eczema and/or egg allergy that were categorized by 
severity.  Family history, seen as a moderate risk factor for food allergy, was also 
assessed.   
 Stakeholder meetings were set up at this clinical site to present the NIAID 
guideline and provide education on its importance for clinical practice.  Providers were 
very receptive to the implementation of this practice change.  At these meetings 
providers were educated on the project process and given education materials for 
families of infants who would benefit from safe, early peanut consumption.    
 The allergy risk assessment was implemented by creating a provider alert on the 
six-month wellness form to ask if the patient had any history of eczema, egg allergy, or 
a family history of food allergies.  If risk was identified, the provider educated and 
counseled parents on stating starting peanut containing foods or the need for allergy 
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testing.  After the visit was completed, providers documented the assessment within the 
“allergy” section on the electronic health record (EHR) note.   
Eczema and Egg Allergy Severity  
 Patient history of eczema was measured both through chart review and 
history/review of systems obtained during that visit.  History of egg allergy was also 
questioned and if the patient was positive the type of reaction would be documented.   
Family History 
 Family history is not part of the NIAID guideline recommendations. There has 
been discussion that there is a genetic component to food allergy development.  This 
measure was utilized to assess any association between children at-risk for developing 
food allergy and family history.   
Plans and Recommendations 
 Patients were stratified into high, moderate, and low/no risk categories based 
upon provider assessment.  Allergy testing would be advised to those infants within the 
high-risk group.  Recommendations to start consistent consumption of peanut 
containing foods were given to patients in the mild/moderate category post-assessment.  
Those with low/no risk were advised that the infant could start peanut consumption if 
desired by the family.  This was documented within the education and anticipatory 
guidance section of the note for that patient visit.  
Analysis 
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 Prior to implementation of this project, there was no standard or routine peanut 
allergy risk assessment as part of the six-month well-exam.  Data analysis was 
performed by chart review of provider documentation of risk factors for peanut 
allergies (eczema and/or egg allergy) and family history of food allergies within the visit 
note.  
Ethical Considerations 
 This evidence-based practice project was approved by both the pediatric practice 
that participated and the University of San Diego Institutional Review Board.  There 
were no conflicts of interest in the implementation of this project.  
Results 
 This project consisted of a four-month retrospective chart review of the four 
months immediately prior to the implementation of the practice change.  This was 
followed by a four-month period of data collection after the practice change was 
implemented.  There were a total of 49 six-month well-exams in the pre-implementation 
phase and 40 six-month well-exams in the post-implementation period.  Average age in 
the pre-implementation was 6-month 13 days and post-implementation 6 months 15 
days.  There was a 14.3% prevalence of eczema pre- and 22.5% prevalence post-
implementation.  No children were identified having an egg allergy. Due to a large 
amount of missing data, patient ethnicity was not included in the data analysis.  In 
October 2017, this clinic had a change in the EHR and many patient charts were not 
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updated to include this key data variable.  No children were identified as having an egg 
allergy.   
 There was an improvement in the practice change by adding routine allergy 
assessment to the six-month well-exam.  There was overall provider uptake of allergy 
documentation of 72.5% at the end of data collection.  July, the first month after the 
practice change was implemented, had the lowest documentation rate, 40%, this month 
also had the highest number of visits at 15.  After this first month, the allergy 
assessment was highlighted on the six-month paper provider form and the field for 
documentation was added to the EHR.  After these changes were made, the 
documentation rate increased from 40% to 92.9% from July to August.  September had a 
100% documentation rate and October, the final month had a 90% rate (Figure 1). 
 Seven of the infants who presented for their visit in the pre-implementation 
phase were at risk for developing peanut allergy, none of whom were identified.  In the 
post-implementation phase, nine infants had a history of eczema.  All of these were in 
the mild/moderate category.  Three of these infants that would have benefited from 
education of early peanut consumption were missed.  These children all presented to 
clinic in July (the first month after the practice change was implemented).  There was an 
overall improvement of identifying infants with peanut allergy risk factors by 66% 
(Figure 2). 
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  There were a total of 29 documented allergy risk assessments; of those completed 
6 infants had history of family food allergy.  Food allergies included: pineapple, wheat, 
and Shellfish/Shrimp.  None of the infants who presented to clinical with a family 
history of food allergies had a history of eczema or egg allergy (Figure 3).  
Discussion 
 This project successfully created a practice change, implementing routine allergy 
risk-assessment at the six-month well-exam at a small pediatric office.  Early 
introduction of allergenic foods can reduce allergy prevalence and there remains a large 
gap in knowledge of primary care providers (Abrams et al., 2018).  Providers in primary 
care play a pivotal role in addressing new practice change and early consumption of 
peanuts in high-risk infants.  Through utilization of provider alert and documentation 
field, there was an improvement in assessing infants for peanut allergy risk.    
 Providers at this practice are given thirty-minute time intervals for all well-
exams.  Adding an allergy risk assessment took no more than 3 minutes of provider 
time to assess risk and educate parents.  This could be done within the time it takes to 
do a physical exam and added no cost to the clinic or patients. 
 The benefits to this project have the potential to generate healthcare and patient 
long-term savings.  These savings would be result of decreased Emergency Room (ER) 
visits and reduced medication need because of a reduction in peanut allergy prevalence.  
A report by Blue Cross Blue Shield (2018) estimated that the cost of one ER visit for an 
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anaphylactic episode in 2016 was $1,419, with a $373 out-of-pocket cost.  The cost for an 
epinephrine auto-injector, the medication administered during an allergic reaction, is 
$493 for name brand and $234 for generic. Peanut allergies are a life-long diagnosis and 
purchasing of medication is continuous.  Additionally, one patient with a peanut 
allergy may encounter multiple ER visits throughout his or her lifetime.  Cost savings 
are therefore far greater than demonstrated in this paper.  Implementing allergy 
prevention practices in primary care can significantly reduce lifelong patient health care 
costs.  
 Limitations to this project include the small size of the practice, making it 
difficult to generalize the intervention to larger systems.  Future evidence-based 
practice projects focusing on allergy risk-assessment utilizing a provider alert should be 
done with a larger sample size.   
 In regard to family history, infants with peanut allergy risk factors did not have a 
family history of food allergies.  This was again a small sample size and showed no 
association between risk factors for peanut allergy and family history of food allergy.  
Additional projects similar to this with a larger population may show the association of 
family history of food allergy to risk factors such as eczema.  
 An important barrier to implementation of this project was that this clinic does 
not use computers within patient rooms, which is why paper documentation was used.  
Results did show that use of this reminder and updates to the EHR increased the 
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performance of assessment.  Compliance outcomes may have been improved with 
electronic prompts by in-room charting.  Other contextual factors involved were 
creating provider motivation via updates on compliance and applying a field for 
documentation to create a convenient way for providers to chart the risk-assessment.  
Data collection took over a four-month period, although there was great improvement 
in adherence to change in practice, a longer time period or follow-up would be 
beneficial to assess sustainability. 
 There was only one visit during the month of September.  One of the providers 
who predominately sees the newborn patients was out on leave six months prior.  This 
absence along with temporal/seasonal changes could have influenced a decrease in 
visits. 
 Diagnosing a patient with mild/moderate versus severe eczema is a subjective 
and provider specific; thus, affecting the recommendation to start early consumption of 
peanuts or referral for allergy testing prior to initiating consumption.  Some infants may 
have a later onset of eczema, after age six months.  Providers will need to assess risk 
and address peanut consumption at later ages when a child develops eczema.  
 The NIAID 2017 addendum guideline primarily focuses on implementing peanut 
containing foods into the at-risk infant; those with eczema and/or egg allergy history 
(Togias et al, 2017).  A new research study that assessed food anaphylaxis in children 
and infants showed that of infants presenting to the ER with food allergy, only 21% had 
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a history of eczema/atopic dermatitis (Samady, Trainor, Smith, & Gupta, 2018).  
Outcomes of this trial show that even infants with no risk factors for food allergy could 
still benefit from early peanut consumption.  Additional research and evidence-based 
projects, such as this study, are needed to understand the long-term benefits of this 
novel guideline.  
Conclusion 
 Implementing change into practice is a process that evolves over time.  This 
evidence-based practice project provides baseline implementation of the NIAID 
guidelines to primary prevention of peanut allergies into clinical use.  This project 
provides a framework for future data collection and evidence-based projects on 
allergies that have not been previously studied.  Subsequent projects will be able to 
build off of baseline guidelines and focus on other topics including: precise diagnosis of 
an allergy in primary care, parent perception of early peanut consumption, and reasons 
for provider and patient non-compliance.  The interventions and outcomes of this 
project lay a sustainable foundation to creating provider practice change and 
prevention of lifelong peanut allergies to improve patient outcomes. 
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Summary of NIAID Guideline Addendum 
Addendum Measures Recommendation 
Guideline 1 Severe Eczema and/or Egg 
Allergy 
Consider allergy (IgE or 
skin prick) testing prior to 
consumption of peanut 
containing foods 
Guideline 2 Mild/Moderate Eczema 
and/or Egg Allergy 
Start consistent 
consumption of peanut 
containing foods as early 
as 6 months 
Guideline 3 No Eczema or Egg Allergy May start peanut 
containing foods as early 
as 6 months and with 
cultural preferences 
Note. The 2017 NIAID Addendum Guideline to Prevention of Peanut Allergy in the 







(March 1, 2018 – June 30, 2018) 
Post-Implementation 
(July 1, 2018 – October 31, 2018) 
Total Visits 49 Total Visits 40 
Male 28 (57.1%) Male 24 (60%) 





Public 28 (57.1%) Public 29 (72.5%) 
Private 21 (42.9%) Private 11 (27.5%) 
 
Mean Age at Visit 
 
6 m 13 d 
(5m17d – 8m14d) 
 
Mean Age at 
Visit 
 
6 m 15 d 
(6m1d – 7m29d) 
Eczema 7 (14.3%) Eczema 
 
9 (22.5%) 
Egg Allergy 0 (0%) Egg Allergy 
 
0 (0%) 
Identified at risk by 
Provider 
0 (0%) Identified at risk 
by Provider 
6 (66.7%) 
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Figure 2.  
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Family History of Food Allergy 
 
 











Concluding Essay: Reflections on Growth in Advanced Practice Nursing Role 
 
 Reflecting back on the last four years it is still hard to believe that my time as a 
doctoral student has come to an end.  I have grown incredibly from the start of this 
program and have gained a new perspective on what it means to be a Doctor of 
Nursing Practice (DNP). Transitioning to primary care has allowed me to understand 
the vital importance of health promotion, maintenance, and preventative care.  Growing 
into a DNP over the last four years has given me to confidence to be able to be an 
independent advanced practice provider.  I have developed the knowledge and 
responsibility to care for patients, instill motivation, and create strong patient/provider 
relationships that are vital to all patients, especially those with complex medical 
conditions. 
 Implementing an evidence based-guideline into clinical practice has taught me 
the need for providers to bring research into patient care.  I learned that as a DNP it is 
my responsibility to bring new practices and policies into my direct care in order to 
improve patient outcomes, as well as to evaluate a new change as it evolves.  The 
foundations I have from the process of implementing my own project will help me with 
others as I begin practicing as a DNP.   
 It is bittersweet to officially be done with my time as a doctoral student.  I have 
learned an incredible amount from faculty, preceptors, and my peers who have all 
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mentored me along the way.  I feel prepared to utilize the foundation I have established 































Abstract for CANP 42nd Annual Conference 
 
Peanut allergies are the leading cause of death from food anaphylaxis.  In 2017, the 
National Association of Allergy and Infectious Disease (NIAID) issued a guideline for use by 
primary care providers to identify infants who would benefit from early peanut consumption.   
Many providers have not yet implemented these guidelines in clinical practice.  The purpose of 
this project is to implement a practice change to improve assessment of risk factors for food 
allergies utilizing the NIAID guideline in infants at their six-month well-child examination at a 
pediatric primary care practice.  Risk factors assessed included: a history of eczema and/or egg 
allergy categorized by severity.  Family history, seen as a moderate risk factor for food allergy, 
was also assessed.  The risk assessment was implemented by creating a provider alert on six-
month wellness forms and a field for documentation into the electronic health record.  Providers 
were given education materials for families of infants who would benefit from safe, early peanut 
consumption.  This project is important for clinical practice.  Infants begin consuming solid 
foods at or around six-months of age and this is a critical time to address risk for future allergies 
and educate families on benefits of early consumption of allergenic foods, such as peanuts.  
Providers in primary care play a pivotal role in addressing new practice change.  This project 
provides a framework for provider identifications of at-risk infants to move toward prevention of 
lifelong peanut allergy. 
 









































• It is estimated that 4-6% of children suffer from food allergies and 30.4% 
of those children are allergies to more than one type of food
• Food allergies have increased over the last two decades and are a 
growing public health concern
• Peanut allergies have increased significantly from 0.4% in 1999 to 2% in 
2010 and are the leading cause of death from food anaphylaxis in the 
United States
• Early introduction of peanut protein containing foods can prevent long-
term allergy in at-risk infants
• In 2017 the National Institute of Allergy and Infectious Disease (NIAID) 
changed guidelines to prevent peanut allergies
• Knowledge gaps remain among primary care providers and there is a 







Family history is not part of the NIAID guideline 
addendum; however it is a moderate risk factor for food 
allergy development.  Although food allergies are 
thought to be epigenetic, the influence of genetics on 
food allergy remain unclear.
Family History and Food Allergies
• Providers at clinical site were not utilizing the NIAID 
guidelines in clinical practice and patients were not being 
assessed for peanut allergy risk
• Current patient intake does not specifically ask about 








• The purpose of this project was to implement a practice 
change to adequately assess risk factors for food 
allergies in infants being seen for their six-month well-
child examination at a small, three provider pediatric 
primary care practice in Southern California
• This project was developed through utilizing the 2017 
NIAID Guideline recommendations on early peanut 
consumption in at-risk infants
Purpose/Aims
Framework/EBP Model






• The Learning Early About Peanut Allergy (LEAP) trial showed 
that children with peanut allergy risk factors had both a 86.1% 
and 70% risk reduction in prevalence of peanut allergies in early 
consumption groups compared to peanut avoidance groups at 
60 months (Du Toit et al., 2015)
• The LEAP-On trial resulted in continued 74% reduced 
prevalence of peanut allergy in children with early consumption 
of peanuts after 12 month avoidance period (Du Toit et al., 2016)
• Early Introduction of allergenic foods, such as peanuts, can 
reduce allergy prevalence by up to 18 per 1,000 cases
• Starting allergenic foods in children with eczema may be 
delayed due to false beliefs that these foods should not be 
consumed










• Meetings with providers to discuss need for practice change and obtain approval
July 2018
• IRB Approval









• Poster Presentation at CANP 2019 Conference




















Note. Infants with family hx of food allergies did not 
present to visit w ith hx of eczema or egg allergy
• Implementing an allergy risk assessment and giving education 
adds 3 minutes of provider time done in a routine well child 
visit.
• Counseling parents on early consumption of peanuts can 
greatly reduce development of peanut allergies and decrease 
Emergency Room (ER) visits 
• The estimated cost for one ER visit from an anaphylactic 
episode in 2016 was $1,419 with an out-of-pocket cost of $373; 
the cost for an Epinephrine auto-injector is $234-$493.
• Improved allergy prevention practices in primary care can 
significantly reduce patient health care costs. Costs above are 








• Infants begin consuming solid foods at or around six-months of 
age that is also a time of a routine well-exam
• This is an critical opportunity to address risk for peanut allergy 
development and educate families on benefits of early 
consumption of allergenic foods
• Providers in primary care play a pivotal role in addressing new 
system changes; especially when there is a paradigm shift in 
practice
• This prevention project implemented an evidence-based, 
routine allergy risk assessment of the 6-month infant into 
clinical practice
Conclusions
• This evidence-based practice project demonstrates the 
importance for primary care providers to routinely 
assess for food allergy risk in the six-month infant
• Families can be informed on the importance of early 
peanut introduction at a time where prevention of 
peanut allergy is possible
• Providers may need to consider allergy prevention 
education with all infants as new research indicated a 
small percent of children presenting to the ER with 
food allergy had a history of risk factors
…stay tuned for more updates!
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DNP Essential I:  Scientific 
Underpinnings for Practice 
 
NONPF:  Scientific Foundation 
Competencies 
 
The scientific foundation of nursing 
practice has expanded and includes a 
focus on both the natural and social 
sciences including human biology, 
genomics, science of therapeutics, 
psychosocial sciences, as well as the 
science of complex organizational 
structures.  In addition, philosophical, 
ethical, and historical issues inherent in 
the development of science create a 
context for the application of the natural 
and social sciences. 
2.   Synthesize nursing and 
other scientific and ethical 
theories and concepts to 
create a foundation for 




 Developed a solid foundation 
of human biology and various 
disease states and the 
pathophysiological changes 
within the body (APNC 520). 
Spring 2016 
 Obtained a strong knowledge-
base of the pharmacodynamics 
and pharmacokinetics of drugs 
as well as an understand of how 
to treat various primary care 
conditions through 
pharmacological therapy 
(APNC 523).  
Fall 2016 
 Established an understanding of 
genomics and the pathogenesis 
for various genetic diseases, the 
ethical issues involved, and 
how to assess and educate 
patients and families on their 
own genetic/environmental 
risks (DNPC 622).  
Spring 2018 
 Utilized the ACE Star Model to 
guide development of an EBP 
project to implement a practice 
change and improve food 
allergy risk assessment in 
infants (DNPC 686) 
DNP Essential II:  Organizational & 
System Leadership for Quality 
Improvement & Systems Thinking 
 
NONPF:  Leadership 
Competencies/Health Delivery System 
Competencies 
 
Advanced nursing practice includes an 
organizational and systems leadership 
component that emphasizes practice, 
ongoing improvement of health 
outcomes, and ensuring patient safety.  
Nurses should be prepared with 
sophisticated expertise in assessing 
organizations, identifying system’s 
issues, and facilitating organization-
wide changes in practice delivery.  This 
also requires political skills, systems 
thinking, and the business and financial 
5.  Design, implement, and 
evaluate ethical health care 
delivery systems and 
information systems that 
meet societal needs and 





 Presented a case study 
presentation on the Quality in 
Pediatric Subspecialty Care 
(QPSC) initiative and goals to 
improve care and standardizing 
outcomes of various, rare 
pediatric conditions (DNPC 
626). 
 Constructed a monthly budget 
and analysis for a primary care 
clinic and implications 
regarding a variance report 
(DNPC 653). 
 Developed an understanding of 
the “worth of a Nurse 
Practitioner” and how to 
calculate salary with including 
overhead and marginal costs 
(DNPC 653).  
 Created a “financial case” to 
discuss the money needed and 
revenue projected for 
implementing standing orders 
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acumen needed for the analysis of 
practice quality and costs. 
 
 
to improve HPV vaccination 
rates (DNPC 626). 
 Constructed a three-year 
financial prospectus on clinic 
revenue form improving 
vaccination rates.  Also, gained 
understanding in how to make a 
prospectus for other EBP 
projects. (DNPC 626) 
Spring 2018 
 Wrote a paper regarding 
implementing a program to 
assess peanut allergy risk at 6-
month-old well visits to prevent 
long-term allergy development 
(DNPC 686).  
DNP Essential III:  Clinical 
Scholarship & Analytical Methods for 
Evidence-Based Practice 
 




Scholarship and research are the 
hallmarks of doctoral education.  
Although basic research is viewed as the 
first and most essential form of scholarly 
activity, an enlarged perspective of 
scholarship has emerged through 
alternative paradigms that involve more 
than discovery of new knowledge. These 
paradigms recognize: (1) the 
scholarship of discovery and integration 
“reflects the investigative and 
synthesizing traditions of academic 
life”; (2) scholars give meaning to 
isolated facts and make connections 
across disciplines through the 
scholarship of integration; and (3) the 
scholar applies knowledge to solve a 
problem via the scholarship of 
application that involves the translation 
of research into practice and 
dissemination and integration of new 
knowledge.  
 
4.   Incorporate research 
into practice through 
critical appraisal of 
existing evidence, 
evaluating practice 






 Synthesized and critiqued 
evidence-based practice articles 
of various pathophysiological 
states through Clinical Grad 
Round assignments and related 
to current or future practice. 
(APNC 520).  
 Reviewed current literature to 
develop a PICO question and 
summarized findings to write a 
paper titled “Retinopathy of 
Prematurity and Oxygen 
Saturations in the Premature 
Infant” 
  (DNPC 611).  
Spring 2016 
 Synthesized Complementary 
and Alternative Medicine 
evidence to create a patient 
pamphlet on the safe use of 
milk thistle (APNC 523).  
Fall 2016 
 Presented a case-study 
presentation and the genetic 
components of Prader Willi 
Syndrome and the most up-to-
date treatment (DNPC 622). 
 Presented and wrote a 
manuscript regarding 
Hemophilia, its pathogenesis, 
treatment, implications for 
patients, and future (DNPC 
622).  
 Created a screening program 
and recommendations for skin 
cancer at primary care  
appointments and how to assess 
risk (DNPC 625).  
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Sumer 2017 
 Made a quality improvement 
presentation regarding 
implementing standing orders 
to improve HPV vaccination 
rates (DNPC 653). 
Summer 2018 
 Obtained IRB approval for a 
scholarly project to assess 
peanut allergy risk in the 6-
month-old infant population 
through utilizing the NIAID 
guidelines (DNPC 630). 
DNP Essential IV:  Information 
Systems/Technology & Patient Care 
Technology for Improvement & 
Transformation of Health Care 
 
NONPF:  Technology & Information 
Literacy Competencies 
 
DNP graduates are distinguished by 
their abilities to use information 
systems/technology to support and 
improve patient care and health care 
systems, and provide leadership within 
healthcare systems and/or academic 
settings.  Knowledge and skills related 
to information systems/technology and 
patient care technology prepare the 
DNP graduates apply new knowledge, 
manage individual and aggregate level 
information, and assess the efficacy of 
patient care technology appropriate to a 
specialized area of practice along with 
the design, selection, and use of 
information systems/technology to 
evaluate programs of care, outcomes of 
care, and care systems.  Information 
systems/technology provide a 
mechanism to apply budget and 
productivity tools, practice information 
systems and decision supports, and web-
based learning or intervention tools to 
support and improve patient care. 
 
 
7.  Incorporate ethical, 
regulatory, and legal 
guidelines in the delivery 
of health care and the 
selection, use, and 
evaluation of information 




 Received Biomedical Research 
and Human Certification 
through CITI (DNPC 625).  
Spring 2017 
 Developed an understanding of 
health care technology and 
implementing new informatics 
through work-flows and 
systems development, while 
eliminating lean waste within 
the work environment. (HCIN 
540). 
 Created a report on current 
sleep deficits within the United 
States adult population and 
utilized learned Excel 
knowledge to best display data 
(HCIN 540). 
Summer 2017 
 Gained knowledge on the use 
of standing orders in the EHR 
and how this can streamline 
workflow in patient care 
(DNPC 626).  
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DNP Essential V:  Health Care Policy 
for Advocacy in Health Care 
 
NONPF:  Policy Competencies 
 
Health care policy, whether created 
though governmental actions, 
institutional decision-making, or 
organizational standards, creates a 
framework that can facilitate or impede 
the delivery of health care services or 
the ability of the provider to engage in 
practice to address health care needs.  
Engagement in the process of policy 
development is central to creating a 
health care system that meets the needs 
of its constituents.  Political activism 
and a commitment to policy development 




3.  Demonstrate leadership 
in collaborative efforts to 
develop and implement 
policies to improve health 
care delivery and outcomes 
at all levels of professional 
practice (institutional, 







 Presented and developed a 
manuscript on current health 
care disparities that remain 
within the United States and 
policies relating to Healthy 
People 2020 (DNPC 648). 
 Created a policy brief on 
increasing access to health care 
for children through School-
Based Health Centers (DNPC 
648).  
DNP Essential VI:  Interprofessional 
Collaboration for Improving Patient 
& Population Health Outcomes 
 
NONPF:  Leadership Competencies 
 
Today’s complex, multi-tiered health 
care environment depends on the 
contributions of highly skilled and 
knowledgeable individuals from multiple 
professions.  In order to accomplish the 
IOM mandate for safe, timely, effective, 
efficient, equitable, and patient-centered 
care in this environment, health care 
professionals must function as highly 
collaborative teams.  DNPs have 
advanced preparation in the 
interprofessional dimension of health 
care that enable them to facilitate 
collaborative team functioning and 
overcome impediments to 
interprofessional practice. DNP 
graduates have preparation in methods 
of effective team leadership and are 
1. Demonstrate advanced 
levels of clinical practice 
within defined ethical, 
legal, and regulatory 
parameters in designing, 
implementing, and 
evaluating evidenced-
based, culturally competent 
therapeutic interventions 
for individuals or 
aggregates. 
3.  Demonstrate leadership 
in collaborative efforts to 
develop and implement 
policies to improve health 
care delivery and outcomes 
at all levels of professional 
practice (institutional, 






 Gained the ability, through 
utilizing reflective practice and 
theory, to be a leader when 
practicing and to provide 
therapeutic care to patients 
(DNPC 610).  
Summer 2017 
 Presentation on the QPSC 
process approach toward 
improving pediatric population 
health outcomes through 
national databases, 
improvement collaborates, and 
web-based modules (DNPC 
626). 
Summer 2017-Spring 209 
 Student Representative for the 
San Diego NAPNAP Chapter. 
Fall 2017 
 Gave a podium presentation 
“NICU and Beyond: 
Adventures in Developmental 
Assessment” at the San Diego 
NAPNAP Chapter fall 2017 
event on the premature infant. 
Fall 2018 
 Submitted an abstract in 
fulfilment of DNP project that 
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prepared to play a central role in 
establishing interprofessional teams, 
participating in the work of the team, 
and assuming leadership of the team 
when appropriate. 
 
was accepted to present at the 
CANP 2019 conference (DNPC 
630).  
Spring 2019 
 Data dissemination of DNP 
Project “Spreading the News 
about Peanuts: Implementing 
an Infant Allergy Risk 
Assessment” 
1. DNP Presentation Day 
2. Poster Presentation at CANP 42nd 
2019 Conference 
3. Stakeholder Presentation 
4. Completion of Final Manuscript 
DNP Essential VII:  Clinical 
Prevention & Population Health for 
Improving Nation’s Health 
 
NONPF:  Leadership Competencies 
 
Consistent with national calls for action 
and with the longstanding focus on 
health promotion and disease prevention 
in nursing, the DNP graduate has a 
foundation in clinical prevention and 
population health. This foundation 
enables DNP graduates to analyze 
epidemiological, biostatistical, 
occupational, and environmental data in 
the development, implementation, and 
evaluation of clinical prevention and 
population. 
 
6.  Employ a population 
health focus in the design, 
implementation, and 
evaluation of health care 
delivery systems that 
address primary, 
secondary, and tertiary 
levels of prevention. 
Fall 2016 
 Created secondary screening 
recommendations for skin 
exams at primary care 
appointments (DNPC 625). 
Summer 2017 
 Created a driver diagram on 
improving HPV vaccination 
rates in the pediatric male 
population; discussed the 
primary drivers and need for 
cancer prevention (DNPC 626). 
Fall 2017 
 Developed an understand in 
health promotion for the 
pediatric, adult, and geriatric 
population and 
recommendations for 
prevention (NPTC 602). 
Summer 2018 
 Stated an evidence-based 
practice project on assessing 
peanut allergy risk in the 6-
month-old infant population to 
improve systems on early 
consumption of peanuts and 







DNP Essential VIII:  Advanced 
Nursing Practice 
 
NONPF:  Independent Practice/Ethics 
Competencies 
 
The increased knowledge and 
sophistication of healthcare has resulted 
in the growth of specialization in 
nursing in order to ensure competence 
in these highly complex areas of 
practice.  The reality of the growth of 
specialization in nursing practice is that 
no individual can master all advanced 
roles and the requisite knowledge for 
enacting these roles.   DNP programs 
provide preparation within distinct 
specialties that require expertise, 
advanced knowledge, and mastery in 
one area of nursing practice.  A DNP 
graduate is prepared to practice in an 
area of specialization within the larger 
domain of nursing. 
1.  Demonstrate advanced 
levels of clinical practice 
within defined ethical, 
legal, and regulatory 









 Became proficient on health 
promotion and prevention 
through the lifespan. Utilized 
this knowledge at an adult 
community clinic in an 
underserved population (NPTC 
604). 
Spring 2018 
 Gained competence in the role 
of a Student Health Nurse 
Practitioner as well as 
independence in assessing and 
treating common acute illness 
in both adult and pediatric 
populations (NPTC 605). 
Summer 2018 
 Developed a foundation and 
understanding of pediatric 
gastrointestinal disorders and 
became proficient in the duties 
of the nurse practitioner in 
specialty care (NPTC 
605/NPTC 549). 
Fall 2018 
 Through the Family Health 
Centers ICPP program, 
received advanced knowledge 
of managing mental health and 
substance use disorders in 
primary care and the use of 
“soft handoffs” in clinical 
practice (NPTC 608). 
Spring 2019 
 Became knowledgeable of 
congenital heart defects and the 
role of the PNP in pre-operative 
and post-operative outpatient 
appointments for children 
having cardiac surgery (NPTC 
609). 
